Michael Golembiewski - Feb 28, 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Stock symbol
SEEL
Transactions as of
Feb 28, 2023
Transactions value $
$8,400
Form type
4
Date filed
3/2/2023, 03:06 PM
Previous filing
Mar 4, 2022
Next filing
Mar 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEEL Common Stock Award $8.4K +12.5K +15.93% $0.67 91K Feb 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).